Healthcare | October 10, 2024
WHO declares India has eliminated Trachoma as a public health problem in 2024
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Strategic focus on COCO-model with a nationwide reach of 501 stores
CSPC will receive an upfront payment of $100 million from AstraZeneca
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
He holds a Master’s in Management from the National University of Singapore
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
The net-zero target approval complements the company's near-term emission reduction targets
Subscribe To Our Newsletter & Stay Updated
